# Efficacy of Tolvaptan on ADPKD Patients

> **NCT02729662** · NA · UNKNOWN · sponsor: **Kyorin University** · enrollment: 118 (actual)

## Conditions studied

- Autosomal Dominant Polycystic Kidney Disease

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT02729662
- **Lead sponsor:** Kyorin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729662, "Efficacy of Tolvaptan on ADPKD Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02729662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*